IMMUNPROTEASOMINHIBITOREN
European patent · EP3710458 · In force
Register entry
- Publication number
- EP3710458
- Application number
- EP18822543
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 14, 2018
- Published
- Sep 23, 2020
- Granted
- Mar 25, 2026
- Protection ends at the latest
- Nov 13, 2038
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07F 5/02 (2006.01)
- Priority
- US 201762587376 P 16.11.2017
- PCT application
- PCT/US2018/061140 14.11.2018
- PCT publication
- WO2019/099582 23.05.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 28, 2026
Agent entered
- Representative
- M.ZARDI & CO SA, Via Giovan Battista Pioda 6, 6900 Lugano
Published in Swissreg on 28.04.2026
- Mar 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.03.2026
Parties
Inventor
LOU, Yan
South San Francisco California 94080, US
OWENS, Timothy Duncan
South San Francisco California 94080, US
BRAMELD, Kenneth Albert
South San Francisco California 94080, US
GOLDSTEIN, David Michael
South San Francisco California 94080, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.